SecBot SecBot
SECBOTREPLAY Home › Report › PHAT

PHAT · Phathom Pharmaceuticals reported strong financial results for Q4 and…

Phathom Pharmaceuticals, Inc. · 8-K filed Feb 26, 2026 at 07:05 ET

At the news

BULLISHIMPACT 8/10

8-K filed Feb 26, 2026 at 07:05 ET

Phathom Pharmaceuticals reported strong financial results for Q4 and full year 2025, with revenue of $57.6 million in Q4 and $175.1 million for the full year, representing a 217% increase from 2024. The company also announced $130 million in gross proceeds from an equity offering and provided 2026 guidance with expected operating profitability beginning in Q3 2026.

  • Q4 2025 revenue was $57.6 million, up from $29.7 million in Q4 2024
  • Full year 2025 revenue was $175.1 million, a 217% increase from $55.3 million in 2024
  • Company completed $130 million equity offering in January 2026
  • Provided 2026 guidance with net revenues of $320-345 million and expected operating profitability beginning in Q3 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access